Back to Journals » Breast Cancer: Targets and Therapy » Volume 16

Original Research

The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker

       
Total article views   HTML views PDF downloads Totals
306 Dovepress* 306+ 2 308
Totals 306 2 308
*Since 3 July 2024

View citations on PubMed Central and Google Scholar